Retatrutide vs Tirzepatide: Triple Agonist Comparison 2026
Retatrutide (triple agonist) vs tirzepatide (Zepbound): weight loss, mechanism, trial data, and expected approval timeline.
Start your GLP-1 weight-loss plan from $147/month
Take our 60-second quiz to get matched with a US-licensed provider. Approved online — medication shipped to your door in 3-5 days.
See if I qualify — Free 60-sec quizAvailable online. Shipped directly to your door anywhere in the US.
Quick answer: Retatrutide vs tirzepatide
Retatrutide is an investigational triple receptor agonist (GLP-1 + GIP + glucagon) that may surpass tirzepatide (GLP-1 + GIP) in weight loss efficacy. Early trial data suggests retatrutide may achieve ~24% average weight loss, compared to tirzepatide's confirmed 22.5%. However, retatrutide is not yet FDA-approved — it's in Phase 3 trials with potential approval in 2027-2028. Tirzepatide (Zepbound) is available now and remains the most effective FDA-approved GLP-1 medication.
If you need treatment now, check your eligibility for tirzepatide or see our tirzepatide buying guide.
Start tirzepatide treatment today
FDA-approved · From $199/month · Licensed US providers
Check my eligibilityMechanism comparison
| Feature | Retatrutide | Tirzepatide (Zepbound) |
|---|---|---|
| Receptor targets | GLP-1 + GIP + Glucagon (triple) | GLP-1 + GIP (dual) |
| Manufacturer | Eli Lilly | Eli Lilly |
| FDA status | Phase 3 trials (not approved) | FDA-approved (Nov 2023) |
| Format | Weekly injection (investigational) | Weekly injection |
| Avg weight loss | ~24% (estimated) | ~22.5% (confirmed) |
| Trial program | TRIUMPH (Phase 3) | SURMOUNT (completed) |
Why the glucagon receptor matters
The key difference between retatrutide and tirzepatide is the addition of glucagon receptor agonism. Glucagon has several effects that complement GLP-1 and GIP:
- Increased energy expenditure: Glucagon stimulates the liver to increase metabolic rate, potentially burning more calories
- Reduced liver fat: Glucagon receptor activation may reduce hepatic fat accumulation, beneficial for MASLD/fatty liver
- Appetite suppression: Combined with GLP-1 and GIP, the triple agonism may produce stronger appetite reduction
This triple mechanism is why retatrutide may exceed tirzepatide in weight loss — the glucagon component adds an energy expenditure pathway that dual agonists don't have.
Weight loss comparison
| Medication | Avg Weight Loss | Trial Duration | Data Quality |
|---|---|---|---|
| Retatrutide | ~24% | 48 weeks (Phase 2) | Early — Phase 3 pending |
| Tirzepatide (Zepbound) | ~22.5% | 72 weeks (SURMOUNT-1) | Strong — Phase 3 complete |
| Semaglutide (Wegovy) | ~15% | 68 weeks (STEP-1) | Strong — Phase 3 complete |
| CagriSema | ~25% (estimated) | Phase 3 ongoing | Early — Phase 3 pending |
See our full GLP-1 comparison guide and CagriSema guide for more pipeline medications.
Expected retatrutide timeline
- Phase 3 trials (TRIUMPH): Ongoing in 2026
- Results expected: Late 2026 to mid 2027
- FDA submission: Potentially 2027
- FDA approval: Potentially 2027-2028
What to do while waiting
If you need GLP-1 treatment now, tirzepatide (Zepbound) is the most effective FDA-approved option:
- LillyDirect Zepbound — brand-name from $299/month
- Eden compounded tirzepatide — from $199/month
- Mochi Health compounded tirzepatide — $278/month flat
Check your eligibility or compare all options in our best GLP-1 telehealth guide.
The bottom line
Retatrutide is a promising triple agonist that may surpass tirzepatide in weight loss efficacy, but it's not yet available. Tirzepatide (Zepbound) remains the most effective FDA-approved GLP-1 medication at 22.5% average weight loss. When retatrutide is approved, we'll update this guide with pricing, availability, and prescribing information. For now, start with tirzepatide if you want the highest weight loss available.
Ready to start? Get GLP-1 prescribed online this week
Join 50,000+ patients who lost 15-22% of body weight with the right GLP-1 medication. Free consultation — no insurance needed.
Check if I qualify — Free 60-sec quizAvailable online. Shipped directly to your door anywhere in the US.
Real patients. Real results.
Join 50,000+ patients who transformed their lives with GLP-1 medications
"I tried everything — keto, intermittent fasting, gym memberships. Nothing worked long-term. GLP-1 changed everything. I lost 47 pounds in 8 months and finally feel like myself again. The online process was so easy — I had my prescription in 2 days."
Jessica M., 38
Texas
-47 lbs
in 8 months
Compounded semaglutide
"At 52, my doctor said I was heading toward diabetes. I started tirzepatide through a telehealth program and lost 62 pounds. My A1C is back to normal, my blood pressure dropped, and I'm off two medications. Wish I'd done this years ago."
David R., 52
Florida
-62 lbs
in 11 months
Tirzepatide (Zepbound)
"I was skeptical about doing this online, but the whole process was professional and easy. My provider answered all my questions, and the medication arrived in 4 days. I've lost 38 pounds and finally have energy to play with my kids again."
Aisha K., 34
California
-38 lbs
in 6 months
Compounded semaglutide
Results vary. These testimonials reflect individual experiences and are not typical. Weight loss depends on diet, activity, and adherence to medication.
How it works — 3 simple steps
Take the 60-second quiz
Answer a few questions about your health, weight goals, and medical history. It's free and confidential.
1 min
Meet your US-licensed provider
A board-certified clinician reviews your profile and prescribes the right GLP-1 medication for you — entirely online.
24-48 hrs
Get medication shipped to your door
Your prescription is filled by a US pharmacy and delivered in discreet packaging in 3-5 business days.
3-5 days
Get GLP-1 savings alerts & weekly tips
Join 50,000+ readers. Price drops, new coupons, and expert weight-loss advice — delivered weekly. Unsubscribe anytime.
Free. No spam. Unsubscribe anytime.